{{Rsnum
|rsid=3785074
|Gene=TERF2
|Chromosome=16
|position=69373083
|Orientation=plus
|GMAF=0.2369
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=TERF2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 48.7 | 38.1 | 13.3
| HCB | 83.8 | 14.7 | 1.5
| JPT | 81.4 | 18.6 | 0.0
| YRI | 27.4 | 50.7 | 21.9
| ASW | 43.9 | 42.1 | 14.0
| CHB | 83.8 | 14.7 | 1.5
| CHD | 71.3 | 25.9 | 2.8
| GIH | 35.6 | 54.5 | 9.9
| LWK | 32.1 | 51.4 | 16.5
| MEX | 74.1 | 19.0 | 6.9
| MKK | 19.4 | 43.9 | 36.8
| TSI | 65.7 | 30.4 | 3.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=19766477
|Title=Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis
}}

{{PMID Auto
|PMID=23629941
|Title=Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities study.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}